Fingerprint
Dive into the research topics of 'Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)
Robert Chapman, Loretta Itri, Richard Gralla, David Kelsen, Ephraim Casper, Robert Golbey
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations